Single-dose HPV vaccine highly effective, researchers say
In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.
Nov 18, 2021
0
12
In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.
Nov 18, 2021
0
12
A Yale-led study reveals that low- and middle-income countries that hosted clinical trials for COVID-19 vaccines are receiving proportionately fewer doses of these vaccines, suggesting that there are wealth-based disparities ...
Nov 18, 2021
0
1
Kids ages five to 11 can now be vaccinated against COVID-19 following the Food and Drug Administration's emergency use authorization of the Pfizer Bio-NTech vaccine for this age group and the Centers for Disease Control and ...
Nov 18, 2021
0
2
The United States is set to become the latest country to widen COVID booster eligibility beyond the immunocompromised, elderly and high risk.
Nov 18, 2021
0
1
(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.
Nov 17, 2021
0
84
A promising new approach to potentially treat Alzheimer's disease—and also vaccinate against it—has been developed by a team of UK and German scientists.
Nov 15, 2021
0
789
The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers—with the first vaccinations having already taken place.
Nov 11, 2021
0
4
New research by investigators at the University of Alabama at Birmingham and Emory University is the first to report that the two widely used vaccines against human papillomavirus, or HPV, are safe and generally well tolerated ...
Nov 10, 2021
0
42
The World Health Organization's chief scientist said Tuesday she was looking forward to the "second generation" of COVID-19 vaccines, which could include nasal sprays and oral versions.
Nov 10, 2021
0
4
The EU's drug watchdog said on Wednesday it expects to decide within two months whether to approve Moderna's COVID vaccine for children aged six to 11.
Nov 10, 2021
0
2